SEC Filings TLDR

The SEC filing details the sale of securities by Matthew Crowley, an officer of Jabil Inc. The filing indicates that Crowley sold 182 units of common stock on October 27, 2025, with an aggregate market value of $39,057.20. Additionally, the filing reports two recent transactions within the past three months: a sale of ...

Thomas Fitzpatrick, a director of Iridium Communications Inc., has filed a Form 144 notice indicating his intention to sell 3,331 shares of the company's common stock. The shares were acquired as restricted stock on December 1, 2022, and March 1, 2023. The approximate sale date is set for October 27, 2025, with an aggr...

Barry Flannelly, an officer of Incyte Corporation, exercised stock options for 33,452 shares of common stock on October 27, 2025. The aggregate market value of these shares was approximately $3,068,538.58. Additionally, Flannelly sold a significant number of shares in the past three months, including 18,495 shares on O...

James Ronald Dail, an officer of Huron Consulting Group Inc., has reported significant stock transactions. On March 1, 2025, Dail acquired 578 shares of common stock through restricted stock vesting as part of his compensation. Additionally, Dail sold 1,421 shares on October 3, 2025, for $213,150 and 22 shares on Octob...

The filing details the securities transactions of Boughton Soleil, an officer of Hims & Hers Health, Inc. The notice, dated October 27, 2025, outlines the sale of Class A securities acquired through restricted stock vesting on September 15, 2025. The total amount of securities sold is 2,637 units, with an aggregate mar...

Hagerty Inc. director Robert I. Kauffman filed a Form 144 notice disclosing plans to sell 15,270 shares of common stock with an aggregate market value of $169,802. This follows an extensive series of transactions where Kauffman, through Aldel LLC, sold over 3.5 million shares acquired through December 2021 PIPE financi...

Lucian Bolda, an affiliate of Honeywell International Inc., has filed a Form 144 with the SEC indicating the intent to sell 10,314 shares of common stock acquired as compensation between March 18, 2024, and February 13, 2025. The shares are to be sold on or around October 27, 2025, with an aggregate market value of app...

Jason J Bundick, an officer of Healthcare Services Group, Inc., has filed a Form 144 notice indicating his intention to sell 20,996 shares of the company's common stock. The shares were acquired through the vesting of restricted stock and performance shares between January 4, 2019, and February 24, 2025. The approximat...

Mike Rosenbaum, an officer and director of Guidewire Software, Inc., has filed a Form 144 notice indicating the sale of 1,400 shares of common stock on October 27, 2025, with an aggregate market value of $357,560. The shares were acquired as performance shares on September 15, 2022. Rosenbaum has been actively selling ...

Oaktree Value Opportunities Fund Holdings, L.P., along with other Oaktree Entities, plans to sell 6 million shares of Garrett Motion Inc.'s common stock. The shares, which were acquired on June 12, 2023, through the conversion of Series A Preferred Stock, are scheduled to be sold on October 27, 2025. The aggregate mark...

Kenneth Stacherski, a former officer of GE HealthCare Technologies Inc., has exercised stock options for 4,585 common shares on October 27, 2025. The shares were acquired from GE HealthCare Technologies Inc. and are expected to be sold on the same date, with an aggregate market value of $361,993. Additionally, Stachers...

On October 27, 2025, John J Corkrean, an officer at H.B. Fuller Company, exercised employee stock options for 14,222 shares of common stock. The transaction was executed through a broker payment for a cashless exercise, with the shares being sold on the same day. The aggregate market value of the shares sold was $857,7...

The filing details the securities transactions of Tan Kwang Hooi, an officer of FLEX LTD. The notice date for the filing is October 27, 2025, and the plan adoption date is December 9, 2024. The securities to be sold include 8,980 common shares acquired on June 14, 2024, and 3,520 common shares acquired on June 11, 2024...

Anil R Chitkara, an officer at Evolv Technologies Holdings, Inc., has exercised stock options for 120,000 common shares on October 27, 2025. The shares were acquired from the issuer, and the transaction was a cash payment. Additionally, Chitkara sold 240,000 common shares on October 24, 2025, generating gross proceeds ...

David Fisher, an officer at Enova International, has filed a notice regarding the sale of securities under Rule 144. The filing details the sale of 6,000 common shares acquired through stock options on February 12, 2019, with an aggregate market value of $720,000. Additionally, Fisher reported multiple sales of Enova I...

The filing details the equity transactions of Mark W. Begor, an officer and director of Equifax Inc. The transactions include the sale of 21,386 shares from the Mark W. Begor Two Year Equifax June 2025 Grat trust account, where Begor is a trustee and account stakeholder. Additionally, the filing reports the vesting of ...

The filing discloses the sale of 4,925 shares of common stock by Jamil Farshchi, an officer of Equifax Inc. The shares were acquired through an option granted on February 21, 2020, and were sold on October 27, 2025. The aggregate market value of the shares sold was $1,176,779.50. The transaction was executed through Fi...

Molly Campbell, a director of East West Bancorp Inc, has filed a Form 144 notice indicating her intention to sell 3,155 shares of the company's common stock. The shares were acquired on August 15, 2017, through equity compensation for services rendered. The planned sale is expected to occur on October 27, 2025, with an...

Douglas Paul Krause, an officer of East West Bancorp Inc, has filed a Form 144 with the SEC indicating his intent to sell 10,000 shares of common stock. The shares were acquired through open market purchases and compensation, with 3,000 shares acquired on October 1, 2005, and 7,000 shares acquired on March 4, 2025. The...

Jeffrey Jacobs, an officer of Dayforce, Inc., has filed a Form 144 indicating his intention to sell 353 shares of the company's common stock. The shares were acquired as restricted stock on May 8, 2023, and May 8, 2022. The planned sale is expected to occur around October 27, 2025, with an aggregate market value of $24...

John J. Lupica, an officer of Chubb Ltd, has filed a Form 144 indicating his intention to sell 23,698 shares of Chubb Ltd common stock. The shares were acquired through options granted on February 25, 2016, and are set to be sold on October 27, 2025. The aggregate market value of the shares to be sold is approximately ...

Mario Alberto Accardi, an officer of Centessa Pharmaceuticals plc, has filed a Form 144 to report transactions under a Rule 10b5-1 trading plan. The plan, adopted on February 14, 2025, involves the sale of 8,000 common shares acquired as Founders Shares on January 2, 2020. The approximate sale date is October 27, 2025,...

Matthew Szot, an officer of Cadrenal Therapeutics Inc., has reported multiple transactions involving the sale of common stock under a 10b5-1 trading plan. The transactions occurred between August 27, 2025, and October 24, 2025, with the largest single transaction involving the sale of 10,900 shares for $153,182.06 on S...

Quang X. Pham, an officer of Cadrenal Therapeutics, Inc., has filed a notice of planned sale of 1,315 shares of common stock, acquired as Founders Shares on January 25, 2022. The sale is scheduled for October 27, 2025, with an aggregate market value of $18,396.86. Additionally, Pham has engaged in multiple transactions...

Wendell Wierenga, a director at Cytokinetics, Incorporated, has filed a Form 144 with the SEC detailing his plan to sell 4,375 shares of common stock acquired through the exercise of stock options. The shares were acquired on October 27, 2025, and the sale is planned for the same date. The aggregate market value of the...